SKI Market

Indian Indices

Nifty

26,032.20 -143.55
(-0.55%)

Sensex

84,833.38 -304.89
( -0.36%)

Bank Nifty

59,273.80 -407.55
( -0.68%)

Nifty IT

37,541.25 -8.45
( -0.02%)

Global Indices

Nasdaq

47,501.07 190.74
(0.40%)

Dow Jones

6,850.51 16.88
(0.25%)

Hang Seng

49,315.01 11.73
(0.02%)

Nikkei 225

9,706.66 4.13
(0.04%)

Forex

USD-INR

89.54 0.20
(0.23%)

EUR-INR

103.99 0.41
(0.39%)

GBP-INR

118.45 0.28
(0.24%)

JPY-INR

0.58 0.00
(0.76%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

0.9167078

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

40.63

EPS(TTM)

Face Value()

Div & Yield %

Back

vikas globalone ltd

Orchid Pharma reports consolidated net loss of Rs 5.72 crore in the September 2025 quarter

Nov 12,2025

Net loss of Orchid Pharma reported to Rs 5.72 crore in the quarter ended September 2025 as against net profit of Rs 27.24 crore during the previous quarter ended September 2024. Sales declined 13.10% to Rs 193.52 crore in the quarter ended September 2025 as against Rs 222.70 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	193.52	222.70	-13
OPM %	-0.76	13.62	-
PBDT	5.57	34.53	-84
PBT	-3.33	25.90	PL
NP	-5.72	27.24	PL

26,032.20 -143.55 (-0.55%)

84,833.38 -304.89 ( -0.36%)

59,273.80 -407.55 ( -0.68%)

37,541.25 -8.45 ( -0.02%)

47,501.07 190.74 (0.40%)

6,850.51 16.88 (0.25%)

49,315.01 11.73 (0.02%)

9,706.66 4.13 (0.04%)

89.54 0.20 (0.23%)

103.99 0.41 (0.39%)

118.45 0.28 (0.24%)

0.58 0.00 (0.76%)